60 related articles for article (PubMed ID: 21214407)
1. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.
Chen J; Deangelo DJ; Kutok JL; Williams IR; Lee BH; Wadleigh M; Duclos N; Cohen S; Adelsperger J; Okabe R; Coburn A; Galinsky I; Huntly B; Cohen PS; Meyer T; Fabbro D; Roesel J; Banerji L; Griffin JD; Xiao S; Fletcher JA; Stone RM; Gilliland DG
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14479-84. PubMed ID: 15448205
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan.
Usuki K; Kameda T; Kawano N; Ito T; Hashimoto Y; Shide K; Kawano H; Sekine M; Toyama T; Iizuka H; Sato S; Takeuchi M; Ishizaki J; Maeda K; Nakai M; Yamashita K; Kubuki Y; Shimoda K
Int J Hematol; 2024 Jun; 119(6):722-727. PubMed ID: 38457113
[TBL] [Abstract][Full Text] [Related]
3. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
4. Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.
Chen M; Wang K; Cai X; Zhang X; Chao H; Chen S; Shen H; Wang Q; Zhang R
Hematology; 2021 Dec; 26(1):153-159. PubMed ID: 33491601
[No Abstract] [Full Text] [Related]
5. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and
Wehrli M; Oppliger Leibundgut E; Gattiker HH; Manz MG; Müller AM; Goede JS
Oncologist; 2017 Apr; 22(4):480-483. PubMed ID: 28242791
[TBL] [Abstract][Full Text] [Related]
6. Identification of targetable FGFR gene fusions in diverse cancers.
Wu YM; Su F; Kalyana-Sundaram S; Khazanov N; Ateeq B; Cao X; Lonigro RJ; Vats P; Wang R; Lin SF; Cheng AJ; Kunju LP; Siddiqui J; Tomlins SA; Wyngaard P; Sadis S; Roychowdhury S; Hussain MH; Feng FY; Zalupski MM; Talpaz M; Pienta KJ; Rhodes DR; Robinson DR; Chinnaiyan AM
Cancer Discov; 2013 Jun; 3(6):636-47. PubMed ID: 23558953
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic FGFR Fusions Produce Centrosome and Cilia Defects by Ectopic Signaling.
Nita A; Abraham SP; Krejci P; Bosakova M
Cells; 2021 Jun; 10(6):. PubMed ID: 34207779
[TBL] [Abstract][Full Text] [Related]
8. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
Yamamoto S; Otsu M; Matsuzaka E; Konishi C; Takagi H; Hanada S; Mochizuki S; Nakauchi H; Imai K; Tsuji K; Ebihara Y
PLoS One; 2015; 10(3):e0120841. PubMed ID: 25803811
[TBL] [Abstract][Full Text] [Related]
9. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.
Duckworth CB; Zhang L; Li S
Int J Clin Exp Pathol; 2014; 7(2):801-7. PubMed ID: 24551307
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated signaling pathways in the development of CNTRL-FGFR1-induced myeloid and lymphoid malignancies associated with FGFR1 in human and mouse models.
Ren M; Qin H; Kitamura E; Cowell JK
Blood; 2013 Aug; 122(6):1007-16. PubMed ID: 23777766
[TBL] [Abstract][Full Text] [Related]
11. Acute myeloid leukemia associated with FGFR1 abnormalities.
Lee H; Kim M; Lim J; Kim Y; Han K; Cho BS; Kim HJ
Int J Hematol; 2013 Jun; 97(6):808-12. PubMed ID: 23609419
[TBL] [Abstract][Full Text] [Related]
12. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature.
Hu S; He Y; Zhu X; Li J; He H
Pediatr Hematol Oncol; 2011 Mar; 28(2):140-6. PubMed ID: 21214407
[TBL] [Abstract][Full Text] [Related]
13. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature.
Mozziconacci MJ; Carbuccia N; Prebet T; Charbonnier A; Murati A; Vey N; Chaffanet M; Birnbaum D
Leuk Res; 2008 Aug; 32(8):1304-8. PubMed ID: 18096225
[TBL] [Abstract][Full Text] [Related]
14. 8p11 myeloproliferative syndrome: a review.
Jackson CC; Medeiros LJ; Miranda RN
Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
[TBL] [Abstract][Full Text] [Related]
15. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33).
Guasch G; Mack GJ; Popovici C; Dastugue N; Birnbaum D; Rattner JB; Pébusque MJ
Blood; 2000 Mar; 95(5):1788-96. PubMed ID: 10688839
[TBL] [Abstract][Full Text] [Related]
16. Identification of four new translocations involving FGFR1 in myeloid disorders.
Sohal J; Chase A; Mould S; Corcoran M; Oscier D; Iqbal S; Parker S; Welborn J; Harris RI; Martinelli G; Montefusco V; Sinclair P; Wilkins BS; van den Berg H; Vanstraelen D; Goldman JM; Cross NC
Genes Chromosomes Cancer; 2001 Oct; 32(2):155-63. PubMed ID: 11550283
[TBL] [Abstract][Full Text] [Related]
17. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
